Interius Biotherapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://interiusbio.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety of INT2104 in Participants Aged 18 Years and Older Who Have B-cell Cancer That Came Back After Prior Treatment
Phase 1
Recruiting
- Conditions
- Precursor Cell Lymphoblastic Leukemia-LymphomaLymphomas Non-Hodgkin's B-Cell
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- Interius BioTherapeutics Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT06539338
- Locations
- 🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Australia
🇦🇺Westmead Hospital, Westmead, Australia
News
No news found